Top compounds associated with response to A2ML1


Feature Type Standardized
Nominal ANOVA
mRNA tivozanib GDSC1000 pan-cancer AAC -0.01 0.8
mRNA tosedostat CTRPv2 pan-cancer AAC 0.062 0.1
mRNA tretinoin:carboplatin (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.033 0.4
mRNA tretinoin:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.025 0.5
mRNA triazolothiadiazine CTRPv2 pan-cancer AAC 0.021 0.5
mRNA trifluoperazine CTRPv2 pan-cancer AAC -0.025 0.5
mRNA triptolide CTRPv2 pan-cancer AAC 0.019 0.6
mRNA tubastatin A GDSC1000 pan-cancer AAC 0.048 0.1
mRNA tubastatin A CTRPv2 pan-cancer AAC 0.073 0.1
mRNA valdecoxib CTRPv2 pan-cancer AAC -0.039 0.3
Download CSV